← Back to Search

Intervention Arm for Chronic Kidney Disease (Kidney-CHAMP Trial)

Waitlist Available
Led By Khaled Abdel-Kader, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 24 months
Awards & highlights

Kidney-CHAMP Trial Summary

This trial will test whether an Electronic Health Record-based Population Health Management intervention can improve care for patients with high-risk Chronic Kidney Disease.

Eligible Conditions
  • Chronic Kidney Disease

Kidney-CHAMP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Kidney Failure, Chronic
Secondary outcome measures
Composite medication safety: Inappropriate use of Non-Steroidal Anti-inflammatory Drugs (NSAIDs), glyburide, metformin, gemfibrozil
Hypertension (HTN) Control
+4 more
Other outcome measures
Subgroup analysis hypertension (HTN) control (outcome 2) in participants with uncontrolled BP at baseline (i.e., BP >130/80 at baseline).
Subgroup analysis of composite medication safety (outcome 4) in the subgroup of participants receiving at least 1 of the following medications inappropriately at study enrollment: NSAIDs, glyburide, metformin, gemfibrozil
Subgroup analysis: Use of Renin-Angiotensin-Aldosterone System inhibitors (RAASi) (outcome 3) in participants who are baseline non-users of RAASi

Kidney-CHAMP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Patients will receive a care bundle
Group II: Usual careActive Control1 Intervention
Patients in the usual care arm will continue to receive CKD care guided by their PCPs as per usual care practices (i.e., specialty consultation, pharmacotherapy, nurse education, etc. may be ordered by the PCP according to their usual practice).

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,340,745 Total Patients Enrolled
Vanderbilt University Medical CenterOTHER
856 Previous Clinical Trials
670,596 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,356 Previous Clinical Trials
4,313,470 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians suitable candidates for this investigation?

"The criteria for patient inclusion in this clinical trial requires that they are aged 18 or above, but not exceeding 85."

Answered by AI

Am I qualified to partake in this clinical experimentation?

"This clinical trial is seeking 1650 volunteers aged 18 to 85 with chronic kidney disease (CKD). The applicants must meet the demands of: being over 18, no more than 85 years old, exhibiting a high-level risk in CKD based on validated external and internal models or displaying reduced eGFR levels or having experienced considerable declines in said values within the past year and half."

Answered by AI

Are individuals still able to partake in this investigation?

"According to information hosted on clinicaltrials.gov, the recruitment period for this study has ended; it was initially posted on May 1st 2019 and last updated on September 9th 2022. Despite that fact, there are currently 497 other medical trials searching for volunteers at present."

Answered by AI
~270 spots leftby Apr 2025